World Pharma News

Home News Channels Contact Us Search XING Forums Members Login

Conferences & Events Cellular Imaging & Analysis 2008 Event by European Pharmaceutical Review Sales Force Effectiveness Russia-CIS Strategic Marketing and Branding for the Pharmaceutical Industry Workshop on molecular targets for cancer, Bergen, Norway	Research & Development First call for Innovative Medicines Initiative a success GlaxoSmithKline teams up with academia to develop new medicines of value New FP7 eHealth Project - preDiCT BASF and Transinsight agree to collaborate in exploring alternatives to animal testing
Read more...	Read more...

Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner).

Non progredi est regredi.

World Pharma News .net

Explore the first worldwide Web 2.0 pharmaceutical news portal and 'Vote', 'Comment' or 'Submit' pharmaceutical news articles or other pharmaceutical web resources!
For further information, please visit http://www.worldpharmanews.net

Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.

Email:

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical

news
[ Amgen | AstraZeneca | Boehringer Ingelheim | Bristol-Myers Squibb | GlaxoSmithKline | Janssen-Cilag | Johnson & Johnson | Novartis | Novo Nordisk | Pfizer | Roche | Shire | Takeda ]

European Commission

European Commission - Pharmaceuticals
FDA

FDA

US Food and Drug Administration

Sponsored Ads

Sponsored Ads

World Pharma News .net / Published News

Our RSS News Channels

ATOM 0.3

OPML

Sponsored Ads

Latest News on Janssen-Cilag.com

Latest News on Janssen-Cilag.com

New Antibiotic To Treat Serious Infections
European Authority Recommends Approval of DORIBAX for treatment of nosocomial pneumonia, complicated intra-abdominal and complicated urinary tract infections
Invega� receives marketing authorisation in European Union for threatment of schizophrenia.
Invega� receives marketing authorisation in European Union for threatment of schizophrenia. First Oral Prolonged-Release Medication to Treat Schizophrenia.
Janssen-Cilag International NV submits marketing authorization application in Europe for new antiobiotic.
Janssen-Cilag International NV submits marketing authorization application in Europe for new antiobiotic ceftobiprole, an investigational antibiotic for the treatment of complicated skin and soft tissue infections (cSSTI) including diabetic foot infections.
INVEGA� receives positive opinion from European Committee for Human Medicinal Products (CHMP)
INVEGA� receives positive opinion from European Committee for Human Medicinal Products for Treatment of Schizophrenia.
INVEGA? approved by FDA as new treatment for schizophrenia
The U.S. Food and Drug Administration (FDA) has approved INVEGA? (paliperidone) Extended-Release Tablets, a new atypical antipsychotic, for the treatment of schizophrenia.
Mother & daughters' journey through madness
Out of the Shadow, Susan Smiley's award-winning documentary film, is now available to view on our European Psychiatry 24x7 website www.psychiatry24X7.com.
European Headache Alliance launches at European Parliament with 1st ever Migraine Day of Action
Migraine patients unite to end intolerance and prejudice against people living with migraine
Study shows Topamax� reduces number of monthly migraine days in chronic migraine patients
A study presented at the annual meeting of the 8th EHF demonstrated that chronic migraine sufferers treated preventively with TOPAMAX� (topiramate) experienced fewer migraine-related days per month than those treated with placebo.

Submit to World Pharma News .net

Sponsored Ads

↑ Grab this Headline Animator

Product Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows GlaxoSmithKline responds to FDA on Cervarix� and plans to submit final study data for approval Cervarix�, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme Genzyme Files Applications for Approval of Mozobil in the United States and Europe Romiplostim Data Show Potential Long-Term Efficacy and Safety	Clinical Trials Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128 Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies International study to evaluate efficacy and safety in treating a leading cause of blindness	Corporate Boehringer Ingelheim FENS Award for exceptional research in neuroscience Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case Summary Judgment Granted for SEROQUEL Patent Litigation in the US Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Abbott and Partnership for a Drug-Free America Launch 'Not In My House'	Financial Pfizer Reports Second-Quarter 2008 Results Novartis gains momentum with strong performance in first half of 2008 Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter Novartis completes acquisition of 25% stake in Alcon from Nestl� Shire proposes acquisition of Jerini AG for an equity purchase price of �328 million
Read more...	Read more...	Read more...	Read more...

© World Pharma News - All rights reserved. Terms and Conditions | Contact Us